Novo Raises Forecast as Wegovy Pill Fuels Sales

Novo Nordisk said this year’s declines won’t be as bad as initially expected thanks to the new Wegovy pill, which helped fuel sales in the first quarter. For the year, the worst drop for both profit and sales will be 12%, compared with 13% earlier. Bloomberg's Sanne Wass reports from Copenhagen.

--------

More on Bloomberg Television and Markets



Like this video? Subscribe and turn on notifications so you don't miss any videos from Bloomberg Markets & Finance: https://tinyurl.com/ysu5b8a9

Visit http://www.bloomberg.com for business news & analysis, up-to-the-minute market data, features, profiles and more.



Connect with Bloomberg Television on:

X: https://twitter.com/BloombergTV

Facebook: https://www.facebook.com/BloombergTelevision

Instagram: https://www.instagram.com/bloombergtv/



Connect with Bloomberg Business on:

X: https://twitter.com/business

Facebook: https://www.facebook.com/bloombergbusiness

Instagram: https://www.instagram.com/bloombergbusiness/

TikTok: https://www.tiktok.com/@bloombergbusiness?lang=en

Reddit: https://www.reddit.com/r/bloomberg/

LinkedIn: https://www.linkedin.com/company/bloomberg-news/



More from Bloomberg:

Bloomberg Radio: https://twitter.com/BloombergRadio



Bloomberg Surveillance: https://twitter.com/bsurveillance

Bloomberg Politics: https://twitter.com/bpolitics

Bloomberg Originals: https://twitter.com/bbgoriginals



Watch more on YouTube:

Bloomberg Technology: https://www.youtube.com/@BloombergTechnology

Bloomberg Originals: https://www.youtube.com/@business

Bloomberg Quicktake: https://www.youtube.com/@BloombergQuicktake

Bloomberg Espanol: https://www.youtube.com/@bloomberg_espanol

Bloomberg Podcasts: https://www.youtube.com/@BloombergPodcasts